The fact that everything looks different doesn't mean that all has changed...
Biblio
Export 60 results:
Author [ Title
] Type Year Filters: Author is Jeltsch, Michael [Clear All Filters]
. Outside in and brakes off for lymphatic growth. Science Signaling [Internet]. 2021;14(695). https://www.science.org/doi/10.1126/scisignal.abj5058
Künnapuu and Jeltsch - 2021 - Outside in and brakes off for lymphatic growth (268.05 KB)
Künnapuu and Jeltsch - 2021 - Outside in and brakes off for lymphatic growth (268.05 KB). Lymphatic-to-blood vessel transdifferentiation in zebrafish. Nature Cardiovascular Research [Internet]. 2022;1(6):539 - 541. https://rdcu.be/cOjJ0
. Lymphatics and the eye. [Finnish]. Duodecim Lääketieteellinen Aikakauskirja [Internet]. 2020;136(16):1777-1788. https://www.duodecimlehti.fi/lehti/2020/16/duo15739 Gucciardo et al. Lymphatics and the Eye (English version). (3.31 MB)
Gucciardo et al. Lymphatics and the Eye (English version). (3.31 MB). Lymphatic Vessels in Regenerative Medicine and Tissue Engineering. Tissue Engineering Part B [Internet]. 2016;22(5):1-13. http://online.liebertpub.com/doi/10.1089/ten.TEB.2016.0034 Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB)
Schaupper et al. Tissue Engineering Part B. Review (postprint manuscript = accepted version after peer review). (697.3 KB). The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Basic principles and embryonic development. [bilingual: English, German]. Lymphologie in Forschung und Praxis [Internet]. 2013;17(1):30 - 37. http://jeltsch.org/sites/jeltsch.org/files/JeltschMichael_Lymphforsch2013_30.pdf Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Fundamentals and embryonic development. (2.08 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 1. Grundlagen und Embryonalentwicklung. (1.82 MB)
Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Fundamentals and embryonic development. (2.08 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 1. Grundlagen und Embryonalentwicklung. (1.82 MB). Lymphangiogenesis in Health and Disease [Internet]. 41st European Societry of Lymphology (ESL) Congress. Lausanne, Switzerland: European Group of Lymphology; 2015. http://www.eurolymphology.org/JOURNAL/VOL26-N72-2015/#p=10 Abstract of the Presentation (Michael Jeltsch) (75.34 KB)
Abstract of the Presentation (Michael Jeltsch) (75.34 KB). KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife [Internet]. 2019;8:e44478. https://elifesciences.org/articles/44478 Jha & Rauniyar et al. 2019 (3.84 MB)
Jha & Rauniyar et al. 2019 (3.84 MB). KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?. International Journal of Molecular Sciences [Internet]. 2021;22(24):13545. https://www.mdpi.com/1422-0067/22/24/13545 Koistinen et al. - 2021 - KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not? (1.28 MB)
Koistinen et al. - 2021 - KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not? (1.28 MB). Investigation on the role of biallelic variants in VEGF‐C found in a patient affected by Milroy‐like lymphedema. Molecular Genetics & Genomic Medicine [Internet]. 2020;00:e1389. https://onlinelibrary.wiley.com/doi/abs/10.1002/mgg3.1389 Mukenge et al. 2020 (1.06 MB)
Mukenge et al. 2020 (1.06 MB). Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. FASEB J [Internet]. 2003;17(14):2006 - 13. http://view.ncbi.nlm.nih.gov/pubmed/14597670 Tanja Veikkola et al., FASEB Journal 2006 (598.77 KB)
Tanja Veikkola et al., FASEB Journal 2006 (598.77 KB). Inhibiton of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171. In 98th Annual Meeting of the American-Association-for-Cancer-Research [Internet]. Los Angeles, CA: American Association for Cancer Research; 2007. http://dx.doi.org/10.1158/0008-5472.CAN-07-5809 Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf (236.37 KB)
Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf (236.37 KB). Heterogeneity of the origin of the lymphatic system. [German]. Lymphologie in Forschung und Praxis [Internet]. 2015;19(2):84-88. http://www.dglymph.de/fileadmin/global/pdfs/LymphForsch_2-15.pdf Mattonet & Jeltsch 2015: Heterogeneity of the origin of the lymphatic system. (3.58 MB) Mattonet & Jeltsch 2015: Über die heterogene Herkunft des Lymphgefäßsystems. (288.77 KB)
Mattonet & Jeltsch 2015: Heterogeneity of the origin of the lymphatic system. (3.58 MB) Mattonet & Jeltsch 2015: Über die heterogene Herkunft des Lymphgefäßsystems. (288.77 KB). The genetic causes of primary lymphedema. In: . Erkrankungen des Lymphgefäßsystems. 6th ed. Cologne: Viavital Verlag; 2015. pp. 210-229. Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB)
Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB). Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res [Internet]. 2003;314(1):69 - 84. http://view.ncbi.nlm.nih.gov/pubmed/12942362 Michael Jeltsch et al., Cell and Tissue Research 2003 (562.33 KB)
Michael Jeltsch et al., Cell and Tissue Research 2003 (562.33 KB). Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J [Internet]. 2006;20(9):1462 - 72. http://view.ncbi.nlm.nih.gov/pubmed/16816121 Terhi Kärpänen et al., FASEB Journal 2006 (2.51 MB)
Terhi Kärpänen et al., FASEB Journal 2006 (2.51 MB). Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis. Circulation Research [Internet]. 2016;119(2):210-221. http://circres.ahajournals.org/content/early/2016/05/25/CIRCRESAHA.116.308504 Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis (3.69 MB) Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis: Supplemental Data (3.3 MB)
Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis (3.69 MB) Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis: Supplemental Data (3.3 MB). Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain. Circ Res [Internet]. 2015;116(10):1660-1669. http://circres.ahajournals.org/content/116/10/1660.long
. Functional Analysis of VEGF-B and VEGF-C [Internet]. University of Helsinki. [Helsinki]: Univeristy of Helsinki; 1997. http://urn.fi/URN:NBN:fi-fe977347 Michael Jeltsch, MSc Thesis, 1997 (3.12 MB)
Michael Jeltsch, MSc Thesis, 1997 (3.12 MB). From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders [Internet]. 42nd Congress of the European Society of Lymphology. Mulhouse, France; 2016. http://www.eurolymphology.org/JOURNAL/VOL28-N74-2016/#p=14 Jeltsch 2016: From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders (683.85 KB)
Jeltsch 2016: From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders (683.85 KB). Factors regulating the substrate specificity of cytosolic phospholipase A2-alpha in vitro. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2016;1861(11):1597. Batchu et al. - 2016 - Factors regulating the substrate specificity of cy.pdf (986.25 KB)
Batchu et al. - 2016 - Factors regulating the substrate specificity of cy.pdf (986.25 KB). Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis [Internet]. 2023;26(3):437 - 461. https://link.springer.com/10.1007/s10456-023-09874-9 Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB)
Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB). Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ Res [Internet]. 2007;100(10):1460 - 7. http://view.ncbi.nlm.nih.gov/pubmed/17478734 Salla Keskitalo et al., Circulation Research 2007 (1.98 MB)
Salla Keskitalo et al., Circulation Research 2007 (1.98 MB). Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific Reports [Internet]. 2017;7(1):4916. https://www.nature.com/articles/s41598-017-04982-1
. Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell [Internet]. 2010;18(6):630 - 40. http://view.ncbi.nlm.nih.gov/pubmed/21130043 Denis Tvorogov et al., Cancer Cell 2010 (1.3 MB) Denis Tvorogov et al., Cancer Cell 2010, supplement (828.69 KB)
Denis Tvorogov et al., Cancer Cell 2010 (1.3 MB) Denis Tvorogov et al., Cancer Cell 2010, supplement (828.69 KB). Drug-induced lymphangiogenesis. In 3. Schweizer Lymphsymposium [Internet]. Juzo; 2021. https://doi.org/10.5281/zenodo.6034307 Jeltsch - 2021 - Drug-induced lymphangiogenesis (1.9 MB)
Jeltsch - 2021 - Drug-induced lymphangiogenesis (1.9 MB)